Ironwood Pharmaceuticals (IRWD) Gross Profit (2013 - 2020)

Ironwood Pharmaceuticals (IRWD) has 7 years of Gross Profit data on file, last reported at $115.8 million in Q4 2020.

• For the quarter ending Q4 2020, Gross Profit changed 0.43% year-over-year to $115.8 million; the trailing twelve-month figure through Dec 2020 stood at $386.4 million (down 4.49% YoY), and the FY2020 full-year result was $386.4 million, down 4.49% from the prior year.
• Gross Profit grew to $115.8 million in Q4 2020, from $103.5 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $130.7 million in Q3 2019 to a low of -$21.3 million in Q4 2018.
• A 4-year average of $76.1 million and a median of $79.2 million in 2017 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit tumbled 124.95% in 2018 and surged 642.2% in 2019, its largest moves.
• Tracing IRWD's Gross Profit over 4 years: stood at $85.2 million in 2017, then plunged by 124.95% to -$21.3 million in 2018, then surged by 642.2% to $115.3 million in 2019, then gained by 0.43% to $115.8 million in 2020.
• Business Quant data shows IRWD's Gross Profit at $115.8 million in Q4 2020, $103.5 million in Q3 2020, and $89.4 million in Q2 2020.